| ABH2 | Alkylated DNA repair protein alkB homolog 2 |
| ABH3 | Alkylated DNA repair protein alkB homolog 3 |
| AML | Acute myeloid leukaemia |
| APE1 | AP-endonuclease 1 |
| BER | Base excision repair |
| BRCA | Breast cancer susceptibility protein |
| DDB2 | DNA damage-binding protein 2 |
| DDR | DNA damage response |
| DNA | Deoxyribonucleic acid |
| DNA-PKcs | DNA-dependent protein kinase catalytic subunit |
| DSB | Double stand break |
| EOC | Epithelial ovarian cancer |
| FDA | Food and Drug Administration |
| FEN1 | Flap-endonuclease 1 |
| GG-NER | Global-genome NER |
| gLOH | Genomic patterns of loss of heterozygosity |
| HNPCC | Hereditary nonpolyposis colorectal cancer |
| HR | Homologous recombination |
| ICL | Interstrand crosslink |
| IDL | Insertion/deletion loop |
| IR | Ionizing radiation |
| MDS | Myelodysplastic syndrome |
| MGMT | Methylguanine methyltransferase |
| MLH1 | MutL homolog 1 |
| MMC | Mitomycin C |
| MMR | Mismatch repair |
| MRN | Mre11-Rad50-Nbs1 |
| MSH2 | MutS homolog 2 |
| MSH3 | MutS homolog 3 |
| NER | Nucleotide excision repair |
| NGS | Next-generation sequencing |
| NHEJ | Non-homologous end joining |
| OS | Overall survival |
| PARP | Poly(ADP-ribose) polymerase |
| PARPi | Poly(ADP-ribose) polymerase inhibitor |
| PCNA | Proliferating cell nuclear antigen |
| PD1 | Programmed cell death protein 1 |
| PD-L1 | Programmed cell death ligand 1 |
| PFS | Progression-free survival |
| PLD | Pegylated liposomal doxorubicin |
| PMS2 | Postmeiotic segregation increased 2 |
| PNKP | Polynucleotide kinase/phosphatase |
| Polβ | Polymerase beta |
| ROS | Reactive oxygen species |
| RPA | Replication protein A |
| SDSA | Synthesis-dependent strand annealing |
| SSBR | Single-strand break repair |
| TC-NER | Transcription-coupled NER |
| UV | Ultraviolet |
| XRCC1 | X-ray cross-complementing group 1 protein |